Selzentry

maraviroc MVC (EI)

For heavily treatment-experienced people who have CCR5-TROPIC virus
Entry Inhibitor

Standard Dose

The recommended dose varies depending on other medications being taken but will be either 150, 300, or 600 mg twice daily (available in 150 mg and 300 mg tablets). Can be taken with or without food. Must be taken in combination with another antiretroviral(s).

Approved for adults and children weighing at least 4.4 pounds (2 kg) and having a creatinine clearance of at least 30 mL/min (measure of kidney function). Available in a 20 mg/mL oral solution. Selzentry for children is dosed based on body weight. See the package insert or HHS guidelines for weight-based dosing. The oral solution should be administered using the included press-in bottle adapter and oral dosing syringe.

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose. Before starting Selzentry, a specific blood test called a Trofile is required to determine if this medication will work.
  • Generic and brand name available for 50 mg and 300 mg tablets. Only brand name available for oral solution 20 mg/mL.
  • See package insert for more complete information on potential side effects and interactions.

Manufacturer

ViiV Healthcare
viivhealthcare.com; selzentry.com
(877) 844-8872

AWP

150 mg, 60 tablets: $2,076.10/month
300 mg, 60 tablets: $2,076.10/month
generic: price not available at press time

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments